Skip to main content

GlucaGen News

FDA Medwatch Alert: Eli Lilly and Company Issues Voluntary Nationwide Recall of One Lot of Glucagon® Emergency Kit Due to Loss of Potency

INDIANAPOLIS, Sept. 24, 2021 -- Eli Lilly and Company (NYSE: LLY) is voluntarily recalling lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar (Glucagon for Injection, ...

FDA Medwatch Alert: GlucaGen HypoKit (glucagon [rDNA origin] for injection) by Novo Nordisk Inc: Recall - Detached Needles on Syringe

ISSUE: Novo Nordisk Inc. is recalling six batches of the GlucaGen HypoKit in the U.S. due to two customer complaints from the UK and Portugal involving detached needles on the syringe with Sterile...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Hypoglycemia

GlucaGen patient information at Drugs.com